Jeet Mukherjee
Stock Analyst at BTIG
(4.10)
# 1,573
Out of 4,361 analysts
117
Total ratings
50.6%
Success rate
12.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jeet Mukherjee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MNPR Monopar Therapeutics | Maintained: Buy | $104 | $60.99 | +70.52% | 14 | Jun 1, 2026 | |
| AVBP ArriVent BioPharma | Maintained: Buy | $42 | $29.92 | +40.37% | 2 | May 29, 2026 | |
| AARD Aardvark Therapeutics | Downgraded: Hold | n/a | $3.97 | - | 9 | May 15, 2026 | |
| ARVN Arvinas | Reiterated: Buy | $16 → $18 | $8.00 | +125.00% | 12 | May 13, 2026 | |
| IPHA Innate Pharma | Maintained: Buy | $8 | $1.82 | +339.56% | 4 | May 13, 2026 | |
| AAPG Ascentage Pharma Group International | Maintained: Buy | $48 | $18.45 | +160.16% | 4 | May 13, 2026 | |
| CATX Perspective Therapeutics | Reiterated: Buy | $14 | $3.60 | +288.89% | 9 | May 12, 2026 | |
| BCAX Bicara Therapeutics | Reiterated: Buy | $28 | $19.64 | +42.57% | 5 | May 11, 2026 | |
| VSTM Verastem | Maintained: Buy | $19 → $18 | $3.81 | +372.44% | 4 | May 8, 2026 | |
| IBRX ImmunityBio | Maintained: Buy | $13 → $12 | $7.23 | +65.98% | 6 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 | $29.29 | +326.77% | 5 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $215 | $104.67 | +105.41% | 8 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $3.63 | +203.03% | 4 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $138 | $71.29 | +93.58% | 12 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $16.37 | +83.26% | 10 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $8.97 | n/a | 1 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $91 | $36.28 | n/a | 2 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $0.98 | n/a | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $42 | $35.52 | n/a | 1 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $13.78 | n/a | 1 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $3.53 | n/a | 1 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62 | $27.87 | n/a | 1 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.0001 | n/a | 1 | Apr 1, 2025 |
Monopar Therapeutics
Jun 1, 2026
Maintained: Buy
Price Target: $104
Current: $60.99
Upside: +70.52%
ArriVent BioPharma
May 29, 2026
Maintained: Buy
Price Target: $42
Current: $29.92
Upside: +40.37%
Aardvark Therapeutics
May 15, 2026
Downgraded: Hold
Price Target: n/a
Current: $3.97
Upside: -
Arvinas
May 13, 2026
Reiterated: Buy
Price Target: $16 → $18
Current: $8.00
Upside: +125.00%
Innate Pharma
May 13, 2026
Maintained: Buy
Price Target: $8
Current: $1.82
Upside: +339.56%
Ascentage Pharma Group International
May 13, 2026
Maintained: Buy
Price Target: $48
Current: $18.45
Upside: +160.16%
Perspective Therapeutics
May 12, 2026
Reiterated: Buy
Price Target: $14
Current: $3.60
Upside: +288.89%
Bicara Therapeutics
May 11, 2026
Reiterated: Buy
Price Target: $28
Current: $19.64
Upside: +42.57%
Verastem
May 8, 2026
Maintained: Buy
Price Target: $19 → $18
Current: $3.81
Upside: +372.44%
ImmunityBio
May 8, 2026
Maintained: Buy
Price Target: $13 → $12
Current: $7.23
Upside: +65.98%
May 1, 2026
Reiterated: Buy
Price Target: $125
Current: $29.29
Upside: +326.77%
Apr 1, 2026
Reiterated: Buy
Price Target: $215
Current: $104.67
Upside: +105.41%
Mar 11, 2026
Maintained: Buy
Price Target: $11
Current: $3.63
Upside: +203.03%
Feb 3, 2026
Maintained: Buy
Price Target: $138
Current: $71.29
Upside: +93.58%
Jan 29, 2026
Maintained: Buy
Price Target: $30
Current: $16.37
Upside: +83.26%
May 23, 2025
Reiterated: Hold
Price Target: n/a
Current: $8.97
Upside: n/a
May 23, 2025
Maintained: Buy
Price Target: $91
Current: $36.28
Upside: n/a
May 21, 2025
Maintained: Buy
Price Target: $12
Current: $0.98
Upside: n/a
May 13, 2025
Initiated Coverage: Buy
Price Target: $42
Current: $35.52
Upside: n/a
May 9, 2025
Maintained: Buy
Price Target: $100
Current: $13.78
Upside: n/a
May 7, 2025
Maintained: Buy
Price Target: $10
Current: $3.53
Upside: n/a
Apr 14, 2025
Maintained: Buy
Price Target: $62
Current: $27.87
Upside: n/a
Apr 1, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a